| Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response V Molinier-Frenkel, R Lengagne, F Gaden, SS Hong, J Choppin, ... Journal of virology 76 (1), 127-135, 2002 | 211 | 2002 |
| Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy. NB Romero, S Braun, O Benveniste, F Leturcq, JY Hogrel, GE Morris, ... Hum Gene Ther. 15 (11), 1065-1076., 2004 | 205 | 2004 |
| Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation ML Boulland, J Marquet, V Molinier-Frenkel, P Möller, C Guiter, ... Blood, The Journal of the American Society of Hematology 110 (1), 220-227, 2007 | 180 | 2007 |
| The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages A Carbonnelle-Puscian, C Copie-Bergman, M Baia, N Martin-Garcia, ... Leukemia 23 (5), 952-960, 2009 | 148 | 2009 |
| Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products. H Gahéry-Ségard, V Molinier-Frenkel, C Le Boulaire, P Saulnier, ... The Journal of clinical investigation 100 (9), 2218-2226, 1997 | 146 | 1997 |
| Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes V Molinier-Frenkel, H Gahery-Segard, M Mehtali, C Le Boulaire, S Ribault, ... Journal of virology 74 (16), 7678-7682, 2000 | 137 | 2000 |
| Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics J Moroch, C Copie-Bergman, L de Leval, A Plonquet, N Martin-Garcia, ... The American journal of surgical pathology 36 (11), 1636-1646, 2012 | 86 | 2012 |
| IL4I1: an inhibitor of the CD8+ antitumor T‐cell response in vivo F Lasoudris, C Cousin, A Prevost‐Blondel, N Martin‐Garcia, ... European journal of immunology 41 (6), 1629-1638, 2011 | 74 | 2011 |
| DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance C Chaise, SL Buchan, J Rice, J Marquet, H Rouard, M Kuentz, GE Vittes, ... Blood, The Journal of the American Society of Hematology 112 (7), 2956-2964, 2008 | 71 | 2008 |
| The maturation of murine dendritic cells induced by human adenovirus is mediated by the fiber knob domain V Molinier-Frenkel, A Prévost-Blondel, SS Hong, R Lengagne, S Boudaly, ... Journal of Biological Chemistry 278 (39), 37175-37182, 2003 | 70 | 2003 |
| Dichotomy between factors inducing the immunosuppressive enzyme IL‐4‐induced gene 1 (IL4I1) in B lymphocytes and mononuclear phagocytes J Marquet, F Lasoudris, C Cousin, ML Puiffe, N Martin‐Garcia, V Baud, ... European journal of immunology 40 (9), 2557-2568, 2010 | 66 | 2010 |
| The IL4I1 enzyme: a new player in the immunosuppressive tumor microenvironment V Molinier-Frenkel, A Prévost-Blondel, F Castellano Cells 8 (7), 757, 2019 | 61 | 2019 |
| Identification of prognostic markers in transthyretin and AL cardiac amyloidosis T Damy, A Jaccard, A Guellich, D Lavergne, A Galat, JF Deux, L Hittinger, ... Amyloid 23 (3), 194-202, 2016 | 61 | 2016 |
| Antibacterial properties of the mammalian L-amino acid oxidase IL4I1 ML Puiffe, I Lachaise, V Molinier-Frenkel, F Castellano PloS one 8 (1), e54589, 2013 | 61 | 2013 |
| The immunosuppressive enzyme IL4I1 promotes FoxP3+ regulatory T lymphocyte differentiation C Cousin, A Aubatin, S Le Gouvello, L Apetoh, F Castellano, ... European journal of immunology 45 (6), 1772-1782, 2015 | 54 | 2015 |
| Treatment of t (11; 18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up M Lévy, C Copie-Bergman, V Molinier-Frenkel, A Riou, C Haioun, ... Leukemia & lymphoma 51 (2), 284-290, 2010 | 53 | 2010 |
| An Overview of l-Amino Acid Oxidase Functions from Bacteria to Mammals: Focus on the Immunoregulatory Phenylalanine Oxidase IL4I1 F Castellano, V Molinier-Frenkel Molecules 22 (12), 2151, 2017 | 49 | 2017 |
| Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients V Molinier-Frenkel, CL Boulaire, FAL Gal, H Gahéry-Segard, T Tursz, ... Human gene therapy 11 (13), 1911-1920, 2000 | 48 | 2000 |
| Immunosuppressive enzymes in the tumor microenvironment V Molinier‐Frenkel, F Castellano FEBS letters 591 (19), 3135-3157, 2017 | 41 | 2017 |
| IL-4–Induced Gene 1: A Negative Immune Checkpoint Controlling B Cell Differentiation and Activation L Bod, L Douguet, C Auffray, R Lengagne, F Bekkat, E Rondeau, ... The Journal of Immunology 200 (3), 1027-1038, 2018 | 37 | 2018 |
Flavia CastellanoVerified email at inserm.fr
